JP2005508338A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508338A5 JP2005508338A5 JP2003532004A JP2003532004A JP2005508338A5 JP 2005508338 A5 JP2005508338 A5 JP 2005508338A5 JP 2003532004 A JP2003532004 A JP 2003532004A JP 2003532004 A JP2003532004 A JP 2003532004A JP 2005508338 A5 JP2005508338 A5 JP 2005508338A5
- Authority
- JP
- Japan
- Prior art keywords
- immunoglobulin
- use according
- composition
- route
- antacid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108060003951 Immunoglobulin Proteins 0.000 description 19
- 102000018358 immunoglobulin Human genes 0.000 description 19
- 239000000203 mixture Substances 0.000 description 10
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 5
- 229940069428 antacid Drugs 0.000 description 5
- 239000003159 antacid agent Substances 0.000 description 5
- 230000001458 anti-acid effect Effects 0.000 description 5
- 208000029560 autism spectrum disease Diseases 0.000 description 3
- 229940099472 immunoglobulin a Drugs 0.000 description 3
- 229940027941 immunoglobulin g Drugs 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32704301P | 2001-10-04 | 2001-10-04 | |
| US38096002P | 2002-05-16 | 2002-05-16 | |
| PCT/US2002/033322 WO2003028668A2 (en) | 2001-10-04 | 2002-10-04 | Gammaglobulin treatment of immune disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508338A JP2005508338A (ja) | 2005-03-31 |
| JP2005508338A5 true JP2005508338A5 (cg-RX-API-DMAC7.html) | 2006-01-05 |
Family
ID=26985697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003532004A Pending JP2005508338A (ja) | 2001-10-04 | 2002-10-04 | 免疫性疾患を処置するためのガンマグロブリンの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20030099635A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1463527A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005508338A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2462682A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04003156A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003028668A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003082217A2 (en) * | 2002-03-29 | 2003-10-09 | Repligen Corporation | Ctla4 compositions in the treatment of autism |
| US20090280114A1 (en) * | 2002-04-12 | 2009-11-12 | Ramot At Tel Aviv University Ltd. | Prevention of brain inflammation as a result of induced autoimmune response |
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| WO2006014911A2 (en) * | 2004-07-26 | 2006-02-09 | Kossor David C | Treatment of inflammatory, autoimmune, or other disorders, using agents that reduce the sequestering of zinc by calprotectin |
| JP2007284351A (ja) * | 2004-07-27 | 2007-11-01 | Osaka Bioscience Institute | アミロイド蛋白質の凝集を抑制する物質とその作用 |
| US20060205012A1 (en) * | 2004-12-09 | 2006-09-14 | Meso Scale Technologies, Llc | Diagnostic test |
| PT1954718E (pt) | 2005-11-30 | 2014-12-16 | Abbvie Inc | Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos |
| PL1976877T5 (pl) | 2005-11-30 | 2017-09-29 | Abbvie Inc | Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
| CA2695972A1 (en) | 2007-08-13 | 2009-02-19 | Baxter Healthcare S.A. | Ivig modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease |
| US20100158893A1 (en) * | 2008-12-19 | 2010-06-24 | Baxter International Inc. | Systems and methods for obtaining immunoglobulin from blood |
| EP2427497B1 (fr) * | 2009-05-07 | 2016-12-07 | Stallergenes | Utilisation d'immunoglobulines igg1 et/ou de ligands du récepteur cd32 pour le traitement de maladies et manifestations inflammatoires par voie mucosale |
| US8546548B2 (en) | 2009-05-27 | 2013-10-01 | Baxter International Inc. | Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
| CN102933601B (zh) | 2010-04-15 | 2016-06-08 | Abbvie公司 | β淀粉样蛋白结合蛋白 |
| US20130034541A1 (en) * | 2010-04-23 | 2013-02-07 | Probiotec Limited | Pharmaceutical compositions |
| US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
| AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
| US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| MX358739B (es) | 2010-08-14 | 2018-09-03 | Abbvie Inc Star | Proteinas de union a amiloide beta. |
| SI2961426T1 (sl) | 2013-02-26 | 2020-01-31 | Baxalta GmbH | Zdravljanje motenj centralnega živčnega sistema z intranazalnim dajanjem imunoglobulina G |
| WO2014182631A1 (en) | 2013-05-06 | 2014-11-13 | Baxter International Inc. | Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g |
| US10478493B2 (en) | 2015-08-31 | 2019-11-19 | Stolle Milk Biologics, Inc. | Method of treating protozoal gastrointestinal disorders in immunocompromised patients |
| ES2690178A1 (es) * | 2017-05-18 | 2018-11-19 | Apc Europe Slu | Plasma de animal o fracciones del mismo para su utilización en el tratamiento de trastornos de deterioro cognitivo en seres humanos y animales de compañia |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE33565E (en) * | 1978-02-06 | 1991-04-02 | Stolle Research And Development Corporation | Prevention and treatment of rheumatioid arthritis |
| US4477432A (en) * | 1981-05-01 | 1984-10-16 | Cutter Laboratories, Inc. | Oral immune globulin |
| US4897265A (en) * | 1983-10-27 | 1990-01-30 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
| US5242691A (en) * | 1982-06-03 | 1993-09-07 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
| US5106618A (en) * | 1987-07-02 | 1992-04-21 | Stolle Research And Development Corporation | Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product |
| ATE158180T1 (de) * | 1991-06-21 | 1997-10-15 | Univ Cincinnati | Oral verabreichbare therapeutische proteine und herstellungsverfahren |
| US5888511A (en) * | 1993-02-26 | 1999-03-30 | Advanced Biotherapy Concepts, Inc. | Treatment of autoimmune diseases, including AIDS |
| US5455160A (en) * | 1993-05-27 | 1995-10-03 | Fagerhol; Magne K. | Diagnostic test and kit for disease or disorders in the digestive system |
| US5681571A (en) * | 1993-10-08 | 1997-10-28 | Duotol Ab | Immunological tolerance-inducing agent |
| US6090380A (en) * | 1994-01-12 | 2000-07-18 | Research Corporation Technologies, Inc. | Treatment of rheumatoid arthritis by oral administration of pooled human immunoglobulin |
| JPH10212246A (ja) * | 1997-01-30 | 1998-08-11 | Nippon Zoki Pharmaceut Co Ltd | 経口投与用製剤 |
| WO2000011014A1 (en) * | 1998-08-25 | 2000-03-02 | Human Genome Sciences, Inc. | 49 human secreted proteins |
| JP2002501616A (ja) * | 1997-05-19 | 2002-01-15 | リプリゲン コーポレーション | 自閉的症候群を鑑別診断および治療する際の助けとするための方法 |
| US20020114802A1 (en) * | 1998-02-10 | 2002-08-22 | Tjellstrom Bo Arthur Einar | Oral immunoglobulin treatment for inflammatory bowel disease |
| EP1076665A1 (en) * | 1998-05-07 | 2001-02-21 | Research Corporation Technologies, Inc | Oral administration of immunoglobulins for treating autoimmune hearing loss |
| EP1171161A1 (en) * | 1999-04-19 | 2002-01-16 | Richard Weisbart | Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid |
| US6187309B1 (en) * | 1999-09-14 | 2001-02-13 | Milkaus Laboratory, Inc. | Method for treatment of symptoms of central nervous system disorders |
-
2002
- 2002-10-04 EP EP02782181A patent/EP1463527A4/en not_active Withdrawn
- 2002-10-04 US US10/264,564 patent/US20030099635A1/en not_active Abandoned
- 2002-10-04 CA CA002462682A patent/CA2462682A1/en not_active Abandoned
- 2002-10-04 JP JP2003532004A patent/JP2005508338A/ja active Pending
- 2002-10-04 MX MXPA04003156A patent/MXPA04003156A/es unknown
- 2002-10-04 WO PCT/US2002/033322 patent/WO2003028668A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508338A5 (cg-RX-API-DMAC7.html) | ||
| UA41995C2 (uk) | Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти ) | |
| WO2004071529A3 (en) | Uses of anti-insulin-like growth factor i receptor antibodies | |
| WO2006059108A3 (en) | ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES | |
| CY1118849T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| EA200301165A1 (ru) | Лекарственное средство на основе оксикодона | |
| ES2089027T3 (es) | Forma de dosificacion transmucosica. | |
| JP2015512406A5 (cg-RX-API-DMAC7.html) | ||
| JP2004504406A5 (cg-RX-API-DMAC7.html) | ||
| JP2007523091A5 (cg-RX-API-DMAC7.html) | ||
| JP2002528502A5 (cg-RX-API-DMAC7.html) | ||
| CA2436540A1 (en) | Pharmaceutical compositions based on anticholinergics and corticosteroids | |
| RU2005126412A (ru) | Сор1 для лечения воспалительных заболеваний кишечника | |
| JP2002524415A5 (cg-RX-API-DMAC7.html) | ||
| JP2006516571A5 (cg-RX-API-DMAC7.html) | ||
| CA2240717A1 (en) | Method of treating and diagnosing sleep disordered breathing and means for carrying out the method | |
| JP2024152860A5 (cg-RX-API-DMAC7.html) | ||
| JP2005508963A5 (cg-RX-API-DMAC7.html) | ||
| JP2004537500A5 (cg-RX-API-DMAC7.html) | ||
| Sheoran | Buccal drug delivery system: A review | |
| JP2002523437A5 (cg-RX-API-DMAC7.html) | ||
| JP2005525329A5 (cg-RX-API-DMAC7.html) | ||
| JPS6345218A (ja) | Ｄ―フェンフルラミン含有うつ病用医薬組成物 | |
| JP2002540148A5 (cg-RX-API-DMAC7.html) | ||
| JP2001518481A (ja) | 経口投与のためのセロトニン含有製剤及びその使用方法 |